Sponsored by ZEISS
“We cover the four main steps of the Retina Workflow—that is, assessing and educating, planning, treating and checking on how our patients respond to therapy.”
Eric Schneider, MD
Retina specialists value efficiency in today’s healthcare and ophthalmology with a growing aging population, increased patient load, personnel shortages and challenging economic trends. An optimized workflow in the retina clinic—from diagnosis with the slit-lamp to advanced multi-modal imaging modalities to treatment and disease management—relies on interconnected technology and digitization.
At ZEISS, we drive the progress, efficiency and access to medical technology supporting healthcare practitioners to improve their patients’ quality of life. For more than 100 years, ZEISS Medical Technology has been setting new standards in care with innovations designed to improve clinical performance and patient outcomes. Today, ZEISS continues its leadership in medical technology by shaping the digital transformation of ophthalmology with a fully connected environment and innovative digital solutions that are setting the standard for new ways to manage care at scale and solving the challenges clinicians face every day.
ZEISS Ultra-widefield imaging and OCT technology deliver high-quality images so you can assess pathology quickly and accurately.
The ZEISS Retina Workplace empowers providers to perform longitudinal analysis in a single interface, registering multi-modal data, for a greater perspective.
Cut down on your patients' chair time, and have more face to face time so you can inform, empower and educate patients on wellness and prevention.
Improve care for patients with:
With the ZEISS Retina Workflow, you can optimize retinal disease detection, management, and treatment.
Click to explore
1. Assess and Educate
Proactive identification and management of retinal conditions is paramount in helping preserve patients’ vision
“Assessing and educating involves examining the patient and providing feedback to the patient about their disease. For this, we rely on top-of-the-line examination equipment like the SL 800 slit lamp from ZEISS.”
Eric Schneider, MD
ZEISS is with you from the moment your patient sits in the chair. The ZEISS SL 800 enables convenient capture of high-quality images and videos for documentation, patient education, or publishing.
TrueView Optics: apochromatic ZEISS lenses with anti-reflex coating provide you with true-to-life color and high contrast images.
TrueView Optics: apochromatic ZEISS lenses with anti-reflex coating provide you with true-to-life color and high contrast images.
VarioLight: the integrated LED light source is accompanied by a halogen filter giving you advantages of both illumination characteristics.
Continuous magnification steps – 6x, 10x, 16x, 25x, 40x – show more detailed structures and give you enhanced insights.
Learn more about the ZEISS SL 800
Watch
An Ophthalmologist's Best Friend...
Ronald Yeoh, MD, MBBS, FRCS, FRCO, DO, FAMS
2. Plan
Visualizing management pathways
“After diagnosing a patient, we plan treatment. Often times, we rely on imaging. The CLARUS 700 fundus camera and the CIRRUS 6000 OCT help guide treatment decisions.”
Eric Schneider, MD
Visualizing retinal pathology is a key driver in clinical decisions to treat or manage.
Linking high-quality OCT and UWF images and data with smart software solutions, you can make better informed decisions and create for your patients effective treatment plans.
ZEISS CIRRUS 6000 OCT: High-speed image capture with HD imaging detail and a wide field of view
100K scans/second delivering high-speed image capture with HD imaging detail and larger field of view—up to 12mm in a single scan
100K scans/second delivering high-speed image capture with HD imaging detail and larger field of view—up to 12mm in a single scan
Macular thickness change maps help you understand your patient‘s response to treatment. Because every CIRRUS cube is tracked and registered to OCT scans from prior visits using CIRRUS' FastTrac™ Retinal Tracking Technology, you can confidently measure point-to-point changes in macular thickness.
Advanced RPE Analysis, available on the ZEISS CIRRUS OCT, was specifically created to help clinicians manage non-neovascular AMD in all its forms. It can automatically and objectively compare an image against a baseline scan to detect GA progression. The progression analytics can be used to detect any increase in GA and encroachment onto the fovea.
OCT angiography (OCTA) systems such as the ZEISS CIRRUS AngioPlex®, is a non-invasive modality for imaging ocular vasculature and incredibly effective imaging modality for detecting and following macular neovascularization (MNV).
ZEISS CLARUS 700 UWF: Comprehensive imaging that combines ultra-widefield imaging with True Color to provide excellent clarity and a full suite of imaging modalities.
One capture wide field 133 covers ETDRS and signs of early DR
One capture wide field 133 covers ETDRS and signs of early DR
7.3 micron high-resolution imaging aids in early detection of AMD
True Color allows visualization of tumors and melanoma
Additional imaging modalities includes FA imaging which captures early sequence, FAF-B and FAF-G for diagnosing AMD
Learn more about the ZEISS CIRRUS 6000 OCT and ZEISS CLARUS 700 UWF
Watch
Using multi-modality in ZEISS Retina Workplace: A case of Neovascular AMD
Eric Schneider, MD
Complex Cases in Retina
Sarah P. Read, MD PhD
Real World Experience with ZEISS CLARUS® 700
Jesse Jung, MD
Imaging of the Fundus in Diabetes
Jean-François Korobelnik, MD, FEBO
Navigating Geographic Atrophy with Advanced Imaging and ZEISS Retina Workflow
Ricardo Guerra, MD, MSc, FICO
Biomarkers in Geographic Atrophy
Enrico Borrelli, MD, PhD, FEBO
Listen
How Imaging Helps Clinics Integrate New Therapies in GA
Aleksandra Rachitskaya, MD; Mrinali Gupta, MD; Katherine Talcott, MD
Read
Improved Technology, Speedier Clinics, and Tailored Treatments
Royce W.S. Chen, MD; Jesse J. Jung, MD; Sunil K. Srivastava, MD
Read on Retina Today →3. Treat
Managing surgery expectations with patients is critical and using the right surgical care tools will give you the confidence you need to ensure the best outcomes for your patients.
“Two pieces of equipment are integral at the point of treatment: the VISULAS green laser and the ARTEVO 3D digital microscope. When using these platforms within the ZEISS Retina Workflow, we rely on data acquired from the two previous steps—assess and educate as well as planning—to execute the treat step.”
Eric Schneider, MD
The photocoagulator ZEISS VISULAS® green from ZEISS turns daily clinical routine into a more convenient and efficient treatment experience.1
ZEISS laser slit lamp: the premium optics of the LED laser slit lamps ensure high visibility of the treatment area. The true-to-color physician’s safety ClearView filter remains active to ensure a safe treatment for the operator.
ZEISS laser slit lamp: the premium optics of the LED laser slit lamps ensure high visibility of the treatment area. The true-to-color physician’s safety ClearView filter remains active to ensure a safe treatment for the operator.
Panel PC: Check patient conditions prior treatment & save laser reports for follow up
VITE multi-spot photocoagulation: the ZEISS VISULAS green comfort model, with VITE option, includes multisport photocoagulation to help reduce treatment times. The short multi-spot pulse durations create smaller lesions to decrease the pain perception.
VISULAS green comfort laser console: Compact laser console with dual port/single port
Learn more about the ZEISS VISULAS® green
Watch
How ZEISS VISULAS green is improving my workflow efficiency in laser therapy
Tim Hillson, MD, MA FRCSC
ZEISS ARTEVO 850 - Setting the pace in digital visualization ARTEVO® 850 from ZEISS rises to the challenges of tackling complexity in ophthalmic surgery. It combines proven benefits of a 3D digital ophthalmic microscope with customizable visualization, functional integration, excellent usability and digital connectivity within the ZEISS Medical Ecosystem.
Reduce manual interactions in your clinical workflow: AutoAdjust® automatically adjusts settings without additional interaction – for example, when switching intraoperatively between anterior and posterior surgery mode.
Excellent usability with new ZEISS CALLISTO eye 5.0
Reduce manual interactions in your clinical workflow: AutoAdjust® automatically adjusts settings without additional interaction – for example, when switching intraoperatively between anterior and posterior surgery mode.
Accentuate anatomical details with digital color coding on a click via the Digital Color Assistant (DCA). Pre-set DCA configurations include bluish color coding.
Observe surgical maneuvers in retinal tissue with intraoperative OCT adding a real-time dimension for viewing transparent structures of the eye.
4. Check
Record treatment decisions over time to help assess treatment effectiveness.
“Finally, we check to our patients’ responses to therapy over time. By leveraging the power of the ZEISS Retina Workplace, we can integrate all imaging information into a single, easily accessible repository with excellent longitudinal analytics tools, thereby allowing us to track our patients over time.”
Eric Schneider, MD
Easily and seamlessly integrate multimodal imaging data and compare pathological changes over time with one click: between modalities, over all time periods, and with treatment data.
Navigate multiple analyses simultaneously: Review synchronized data such as OCT macular cubes registered with OCT raster scans and fundus images.
Navigate multiple analyses simultaneously: Review synchronized data such as OCT macular cubes registered with OCT raster scans and fundus images.
Increase certainty with registration of ultra-widefield fundus and OCT images: Correlate and register multi-modality images for visualization and assessment of pathology.
Longitudinal image review allows providers to offer important prognostic information - in AMD change over time can be tracked for any number of parameters, such as lesion distance from the fovea in GA patients or CRT in DME patient
Longitudinal image review allows providers to offer important prognostic information - in AMD change over time can be tracked for any number of parameters, such as lesion distance from the fovea in GA patients or CRT in DME patient
Detect and compare pathological changes over time with one click: Compare 3 exams in a single visualization for the identification of change.
Visualize deeper into the retina with OCT Angiography: Register OCT Angiography data for 3D visualization of microvasculature and gain insights into disease progression.
Visualize deeper into the retina with OCT Angiography: Register OCT Angiography data for 3D visualization of microvasculature and gain insights into disease progression.
Visualize treatment efficiency with visit history charts: Record treatment decisions over time to help assess treatment effectiveness.
Learn more about the ZEISS Retina Workflow
Watch
Overview of ZEISS FORUM with Retina Workplace: A Case of Macular Edema
Eric Schneider, MD
From Drusen to Atrophy: An AMD Journey Unveiled using ZEISS Retina Workflow
Ricardo Leitão Guerra, MD MSc FICO
ZEISS Retina Workflow: How to use multi-modal imaging for Diabetic Retinopathy
Eric Schneider, MD
Using ZEISS Retina Workplace for patient compliance: A longitudinal case of Macular Edema & Diabetic Retinopathy
Eric Schneider, MD
How has ZEISS Retina Workflow assisted you in simplifying your clinical workflow?
Mario Romano, MD
How has ZEISS Retina Workflow assisted you in simplifying your clinical workflow?
Jean-François Korobelnik, MD, FEBO
What are your efficiences with ZEISS FORUM?
Jean-François Korobelnik, MD, FEBO
Listen
Imaging Geographic Atrophy: OCT, FAF, NIR, and OCTA
Rishi P. Singh, MD; Roger A. Goldberg, MD, MBA; Mrinali Gupta, MD; Katherine Talcott, MD
Read
Data Integration for Clinical Decision Making
Peter A. Karth, MD
"Imaging patients quickly and easily with cutting-edge ZEISS technology improves clinical throughput, and using the ZEISS Retina Workflow to efficiently assess and educate patients allows us to maximize our clinical potential while improving the quality of care we deliver. The return on investment is clear."
Eric W. Schneider, MD
"For new patients with AMD, the ZEISS Retina Workflow empowers me to start a patient’s journey from a position of technologic strength."
Ricardo Leitão Guerra, MD
"Evaluating my clinical data environment in this integrated and multi-dimensional way with Retina Workplace has opened my eyes to the future of superior patient care."
Peter A. Karth, MD
"The challenges of managing retinal disease is to have longitudinal information. We have the help of Retinal Workflow, because we can follow the patient part in uh, all the steps. So this is a very important for us, because we can get uh, the changes of the disease and we can get the right timing of the surgery or other any treatment that we need to give to the patient."
Mario Romano, MD
1. Data on file. Dr. Jürgen Walter, personal communication, January 2024.
en-INT_31_174_0261I
The statements of the doctors reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution with whom they are affiliated. The doctors alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec, Inc and its affiliates do not have clinical evidence supporting the opinions and statements of the doctors nor accept any responsibility or liability of the authors’ content.
Not all products, uses, treatment options and protocols referenced are officially approved in every market or supported by a product’s intended use in every market. Approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development.
